Tech Company Financing Transactions
Paragonix Technologies Funding Round
Paragonix Technologies secured a $24 million Series B funding round on 3/7/2023. Backers included Signet Healthcare Partners.
Transaction Overview
Company Name
Announced On
3/7/2023
Transaction Type
Venture Equity
Amount
$24,000,000
Round
Series B
Investors
Signet Healthcare Partners (Lead Investor)
Proceeds Purpose
The company intends to use the funds to bolster its commercial presence, including the ongoing extension of clinical service offerings and inventory expansion, and to further advance transplant innovations.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
639 Granite St. 408
Braintree, MA 02184
USA
Braintree, MA 02184
USA
Phone
Email Address
Overview
Founded in 2010, Paragonix Technologies Inc., is a privately held medical device company innovating the Sherpa Cardiac Transport System, a novel, single-use organ preservation device to improve donor organ quality and extend donor organ preservation times.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
William Edelman
Chief Medical Officer
Leonard Golding
Chief Operating Officer
Lisa Anderson
Vice President
Denise Weber
VP - Bus. Development
Richard Burtt
VP - Operations
Adam Collette
Browse more venture capital transactions:
Prev: 3/7/2023: Amelia venture capital transaction
Next: 3/7/2023: Banyan Infrastructure venture capital transaction
Share this article
News on VC Transactions
We do our best to report on tech company VC transactions. VC investment data records on this site are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs